Shrimps Production are increasing on the global level especially in Asia Pacific countries such as India and China. Shrimp farming is gaining popularity for production of shrimp for human consumption. Bacterial and viral infections are a major threat to the shrimp production industry in various countries. Shrimp production in many countries continues to face economic losses due to different diseases.

The global Shrimps Disease Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Shrimps Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Shrimps Disease Diagnostic.

Report Scope

The Shrimps Disease Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Shrimps Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Shrimps Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Shrimps Disease Diagnostic Market Report

Report Metric	Details
Report Name	Shrimps Disease Diagnostic Market
CAGR	5%
Segment by Type	WSSV (White Spot Syndrome Virus) TSV (Taura Syndrome Virus) YHV/GAV (Yellow Head/Gill Associated Virus) IHHNV (Infectious Hypodermal and Hematopoietic Virus) HPV (Hepatopancreatic Parvovirus) MBV (Monodon Baculovirus) IMNV (Infectious Myonecrosis Virus) NHP-B (Necrotising Hepatopancreatitis Bacteria) MoV (Mourilyan Virus) Early Mortality Syndrome (EMS)
Segment by Application	Fisheries Aquaculture Laboratories Marine Laboratories Education and Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD, GeneReach Biotechnology Corp, Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd, AquaBounty Technologies, Inc, pop bio, SUREBIO, Auro Biotechnologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Shrimps Disease Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Shrimps Disease Diagnostic Market report?

Ans: The main players in the Shrimps Disease Diagnostic Market are HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD, GeneReach Biotechnology Corp, Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd, AquaBounty Technologies, Inc, pop bio, SUREBIO, Auro Biotechnologies

What are the Application segmentation covered in the Shrimps Disease Diagnostic Market report?

Ans: The Applications covered in the Shrimps Disease Diagnostic Market report are Fisheries, Aquaculture Laboratories, Marine Laboratories, Education and Research Institutes, Others

What are the Type segmentation covered in the Shrimps Disease Diagnostic Market report?

Ans: The Types covered in the Shrimps Disease Diagnostic Market report are WSSV (White Spot Syndrome Virus), TSV (Taura Syndrome Virus), YHV/GAV (Yellow Head/Gill Associated Virus), IHHNV (Infectious Hypodermal and Hematopoietic Virus), HPV (Hepatopancreatic Parvovirus), MBV (Monodon Baculovirus), IMNV (Infectious Myonecrosis Virus), NHP-B (Necrotising Hepatopancreatitis Bacteria), MoV (Mourilyan Virus), Early Mortality Syndrome (EMS)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Shrimps Disease Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 WSSV (White Spot Syndrome Virus)

1.2.3 TSV (Taura Syndrome Virus)

1.2.4 YHV/GAV (Yellow Head/Gill Associated Virus)

1.2.5 IHHNV (Infectious Hypodermal and Hematopoietic Virus)

1.2.6 HPV (Hepatopancreatic Parvovirus)

1.2.7 MBV (Monodon Baculovirus)

1.2.8 IMNV (Infectious Myonecrosis Virus)

1.2.9 NHP-B (Necrotising Hepatopancreatitis Bacteria)

1.2.10 MoV (Mourilyan Virus)

1.2.11 Early Mortality Syndrome (EMS)

1.3 Market by Application

1.3.1 Global Shrimps Disease Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Fisheries

1.3.3 Aquaculture Laboratories

1.3.4 Marine Laboratories

1.3.5 Education and Research Institutes

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Shrimps Disease Diagnostic Market Perspective (2019-2030)

2.2 Shrimps Disease Diagnostic Growth Trends by Region

2.2.1 Global Shrimps Disease Diagnostic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Shrimps Disease Diagnostic Historic Market Size by Region (2019-2024)

2.2.3 Shrimps Disease Diagnostic Forecasted Market Size by Region (2025-2030)

2.3 Shrimps Disease Diagnostic Market Dynamics

2.3.1 Shrimps Disease Diagnostic Industry Trends

2.3.2 Shrimps Disease Diagnostic Market Drivers

2.3.3 Shrimps Disease Diagnostic Market Challenges

2.3.4 Shrimps Disease Diagnostic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Shrimps Disease Diagnostic Players by Revenue

3.1.1 Global Top Shrimps Disease Diagnostic Players by Revenue (2019-2024)

3.1.2 Global Shrimps Disease Diagnostic Revenue Market Share by Players (2019-2024)

3.2 Global Shrimps Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Shrimps Disease Diagnostic Revenue

3.4 Global Shrimps Disease Diagnostic Market Concentration Ratio

3.4.1 Global Shrimps Disease Diagnostic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Shrimps Disease Diagnostic Revenue in 2023

3.5 Shrimps Disease Diagnostic Key Players Head office and Area Served

3.6 Key Players Shrimps Disease Diagnostic Product Solution and Service

3.7 Date of Enter into Shrimps Disease Diagnostic Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Shrimps Disease Diagnostic Breakdown Data by Type

4.1 Global Shrimps Disease Diagnostic Historic Market Size by Type (2019-2024)

4.2 Global Shrimps Disease Diagnostic Forecasted Market Size by Type (2025-2030)

5 Shrimps Disease Diagnostic Breakdown Data by Application

5.1 Global Shrimps Disease Diagnostic Historic Market Size by Application (2019-2024)

5.2 Global Shrimps Disease Diagnostic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Shrimps Disease Diagnostic Market Size (2019-2030)

6.2 North America Shrimps Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Shrimps Disease Diagnostic Market Size by Country (2019-2024)

6.4 North America Shrimps Disease Diagnostic Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Shrimps Disease Diagnostic Market Size (2019-2030)

7.2 Europe Shrimps Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Shrimps Disease Diagnostic Market Size by Country (2019-2024)

7.4 Europe Shrimps Disease Diagnostic Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Shrimps Disease Diagnostic Market Size (2019-2030)

8.2 Asia-Pacific Shrimps Disease Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Shrimps Disease Diagnostic Market Size by Region (2019-2024)

8.4 Asia-Pacific Shrimps Disease Diagnostic Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Shrimps Disease Diagnostic Market Size (2019-2030)

9.2 Latin America Shrimps Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Shrimps Disease Diagnostic Market Size by Country (2019-2024)

9.4 Latin America Shrimps Disease Diagnostic Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Shrimps Disease Diagnostic Market Size (2019-2030)

10.2 Middle East & Africa Shrimps Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Shrimps Disease Diagnostic Market Size by Country (2019-2024)

10.4 Middle East & Africa Shrimps Disease Diagnostic Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 HiMedia Laboratories

11.1.1 HiMedia Laboratories Company Detail

11.1.2 HiMedia Laboratories Business Overview

11.1.3 HiMedia Laboratories Shrimps Disease Diagnostic Introduction

11.1.4 HiMedia Laboratories Revenue in Shrimps Disease Diagnostic Business (2019-2024)

11.1.5 HiMedia Laboratories Recent Development

11.2 Speedy Assay Sdn Bhd

11.2.1 Speedy Assay Sdn Bhd Company Detail

11.2.2 Speedy Assay Sdn Bhd Business Overview

11.2.3 Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Introduction

11.2.4 Speedy Assay Sdn Bhd Revenue in Shrimps Disease Diagnostic Business (2019-2024)

11.2.5 Speedy Assay Sdn Bhd Recent Development

11.3 REAGEN LLC

11.3.1 REAGEN LLC Company Detail

11.3.2 REAGEN LLC Business Overview

11.3.3 REAGEN LLC Shrimps Disease Diagnostic Introduction

11.3.4 REAGEN LLC Revenue in Shrimps Disease Diagnostic Business (2019-2024)

11.3.5 REAGEN LLC Recent Development

11.4 FUJIKURA KASEI CO., LTD

11.4.1 FUJIKURA KASEI CO., LTD Company Detail

11.4.2 FUJIKURA KASEI CO., LTD Business Overview

11.4.3 FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Introduction

11.4.4 FUJIKURA KASEI CO., LTD Revenue in Shrimps Disease Diagnostic Business (2019-2024)

11.4.5 FUJIKURA KASEI CO., LTD Recent Development

11.5 GeneReach Biotechnology Corp

11.5.1 GeneReach Biotechnology Corp Company Detail

11.5.2 GeneReach Biotechnology Corp Business Overview

11.5.3 GeneReach Biotechnology Corp Shrimps Disease Diagnostic Introduction

11.5.4 GeneReach Biotechnology Corp Revenue in Shrimps Disease Diagnostic Business (2019-2024)

11.5.5 GeneReach Biotechnology Corp Recent Development

11.6 Thermo Fisher Scientific

11.6.1 Thermo Fisher Scientific Company Detail

11.6.2 Thermo Fisher Scientific Business Overview

11.6.3 Thermo Fisher Scientific Shrimps Disease Diagnostic Introduction

11.6.4 Thermo Fisher Scientific Revenue in Shrimps Disease Diagnostic Business (2019-2024)

11.6.5 Thermo Fisher Scientific Recent Development

11.7 Lab - Ind Resource Sdn Bhd

11.7.1 Lab - Ind Resource Sdn Bhd Company Detail

11.7.2 Lab - Ind Resource Sdn Bhd Business Overview

11.7.3 Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Introduction

11.7.4 Lab - Ind Resource Sdn Bhd Revenue in Shrimps Disease Diagnostic Business (2019-2024)

11.7.5 Lab - Ind Resource Sdn Bhd Recent Development

11.8 AquaBounty Technologies, Inc

11.8.1 AquaBounty Technologies, Inc Company Detail

11.8.2 AquaBounty Technologies, Inc Business Overview

11.8.3 AquaBounty Technologies, Inc Shrimps Disease Diagnostic Introduction

11.8.4 AquaBounty Technologies, Inc Revenue in Shrimps Disease Diagnostic Business (2019-2024)

11.8.5 AquaBounty Technologies, Inc Recent Development

11.9 pop bio

11.9.1 pop bio Company Detail

11.9.2 pop bio Business Overview

11.9.3 pop bio Shrimps Disease Diagnostic Introduction

11.9.4 pop bio Revenue in Shrimps Disease Diagnostic Business (2019-2024)

11.9.5 pop bio Recent Development

11.10 SUREBIO

11.10.1 SUREBIO Company Detail

11.10.2 SUREBIO Business Overview

11.10.3 SUREBIO Shrimps Disease Diagnostic Introduction

11.10.4 SUREBIO Revenue in Shrimps Disease Diagnostic Business (2019-2024)

11.10.5 SUREBIO Recent Development

11.11 Auro Biotechnologies

11.11.1 Auro Biotechnologies Company Detail

11.11.2 Auro Biotechnologies Business Overview

11.11.3 Auro Biotechnologies Shrimps Disease Diagnostic Introduction

11.11.4 Auro Biotechnologies Revenue in Shrimps Disease Diagnostic Business (2019-2024)

11.11.5 Auro Biotechnologies Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

HiMedia Laboratories

Speedy Assay Sdn Bhd

REAGEN LLC

FUJIKURA KASEI CO., LTD

GeneReach Biotechnology Corp

Thermo Fisher Scientific

Lab - Ind Resource Sdn Bhd.

AquaBounty Technologies, Inc.

Pop-Bio

SureBio

Auro Biotechnologies,

List of Tables

Table 1. Global Shrimps Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of WSSV (White Spot Syndrome Virus)

Table 3. Key Players of TSV (Taura Syndrome Virus)

Table 4. Key Players of YHV/GAV (Yellow Head/Gill Associated Virus)

Table 5. Key Players of IHHNV (Infectious Hypodermal and Hematopoietic Virus)

Table 6. Key Players of HPV (Hepatopancreatic Parvovirus)

Table 7. Key Players of MBV (Monodon Baculovirus)

Table 8. Key Players of IMNV (Infectious Myonecrosis Virus)

Table 9. Key Players of NHP-B (Necrotising Hepatopancreatitis Bacteria)

Table 10. Key Players of MoV (Mourilyan Virus)

Table 11. Key Players of Early Mortality Syndrome (EMS)

Table 12. Global Shrimps Disease Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 13. Global Shrimps Disease Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 14. Global Shrimps Disease Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 15. Global Shrimps Disease Diagnostic Market Share by Region (2019-2024)

Table 16. Global Shrimps Disease Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 17. Global Shrimps Disease Diagnostic Market Share by Region (2025-2030)

Table 18. Shrimps Disease Diagnostic Market Trends

Table 19. Shrimps Disease Diagnostic Market Drivers

Table 20. Shrimps Disease Diagnostic Market Challenges

Table 21. Shrimps Disease Diagnostic Market Restraints

Table 22. Global Shrimps Disease Diagnostic Revenue by Players (2019-2024) & (US$ Million)

Table 23. Global Shrimps Disease Diagnostic Market Share by Players (2019-2024)

Table 24. Global Top Shrimps Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shrimps Disease Diagnostic as of 2023)

Table 25. Ranking of Global Top Shrimps Disease Diagnostic Companies by Revenue (US$ Million) in 2023

Table 26. Global 5 Largest Players Market Share by Shrimps Disease Diagnostic Revenue (CR5 and HHI) & (2019-2024)

Table 27. Key Players Headquarters and Area Served

Table 28. Key Players Shrimps Disease Diagnostic Product Solution and Service

Table 29. Date of Enter into Shrimps Disease Diagnostic Market

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global Shrimps Disease Diagnostic Market Size by Type (2019-2024) & (US$ Million)

Table 32. Global Shrimps Disease Diagnostic Revenue Market Share by Type (2019-2024)

Table 33. Global Shrimps Disease Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 34. Global Shrimps Disease Diagnostic Revenue Market Share by Type (2025-2030)

Table 35. Global Shrimps Disease Diagnostic Market Size by Application (2019-2024) & (US$ Million)

Table 36. Global Shrimps Disease Diagnostic Revenue Market Share by Application (2019-2024)

Table 37. Global Shrimps Disease Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 38. Global Shrimps Disease Diagnostic Revenue Market Share by Application (2025-2030)

Table 39. North America Shrimps Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. North America Shrimps Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 41. North America Shrimps Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 42. Europe Shrimps Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Shrimps Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Shrimps Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 45. Asia-Pacific Shrimps Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 46. Asia-Pacific Shrimps Disease Diagnostic Market Size by Region (2019-2024) & (US$ Million)

Table 47. Asia-Pacific Shrimps Disease Diagnostic Market Size by Region (2025-2030) & (US$ Million)

Table 48. Latin America Shrimps Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 49. Latin America Shrimps Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 50. Latin America Shrimps Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 51. Middle East & Africa Shrimps Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 52. Middle East & Africa Shrimps Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)

Table 53. Middle East & Africa Shrimps Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)

Table 54. HiMedia Laboratories Company Detail

Table 55. HiMedia Laboratories Business Overview

Table 56. HiMedia Laboratories Shrimps Disease Diagnostic Product

Table 57. HiMedia Laboratories Revenue in Shrimps Disease Diagnostic Business (2019-2024) & (US$ Million)

Table 58. HiMedia Laboratories Recent Development

Table 59. Speedy Assay Sdn Bhd Company Detail

Table 60. Speedy Assay Sdn Bhd Business Overview

Table 61. Speedy Assay Sdn Bhd Shrimps Disease Diagnostic Product

Table 62. Speedy Assay Sdn Bhd Revenue in Shrimps Disease Diagnostic Business (2019-2024) & (US$ Million)

Table 63. Speedy Assay Sdn Bhd Recent Development

Table 64. REAGEN LLC Company Detail

Table 65. REAGEN LLC Business Overview

Table 66. REAGEN LLC Shrimps Disease Diagnostic Product

Table 67. REAGEN LLC Revenue in Shrimps Disease Diagnostic Business (2019-2024) & (US$ Million)

Table 68. REAGEN LLC Recent Development

Table 69. FUJIKURA KASEI CO., LTD Company Detail

Table 70. FUJIKURA KASEI CO., LTD Business Overview

Table 71. FUJIKURA KASEI CO., LTD Shrimps Disease Diagnostic Product

Table 72. FUJIKURA KASEI CO., LTD Revenue in Shrimps Disease Diagnostic Business (2019-2024) & (US$ Million)

Table 73. FUJIKURA KASEI CO., LTD Recent Development

Table 74. GeneReach Biotechnology Corp Company Detail

Table 75. GeneReach Biotechnology Corp Business Overview

Table 76. GeneReach Biotechnology Corp Shrimps Disease Diagnostic Product

Table 77. GeneReach Biotechnology Corp Revenue in Shrimps Disease Diagnostic Business (2019-2024) & (US$ Million)

Table 78. GeneReach Biotechnology Corp Recent Development

Table 79. Thermo Fisher Scientific Company Detail

Table 80. Thermo Fisher Scientific Business Overview

Table 81. Thermo Fisher Scientific Shrimps Disease Diagnostic Product

Table 82. Thermo Fisher Scientific Revenue in Shrimps Disease Diagnostic Business (2019-2024) & (US$ Million)

Table 83. Thermo Fisher Scientific Recent Development

Table 84. Lab - Ind Resource Sdn Bhd Company Detail

Table 85. Lab - Ind Resource Sdn Bhd Business Overview

Table 86. Lab - Ind Resource Sdn Bhd Shrimps Disease Diagnostic Product

Table 87. Lab - Ind Resource Sdn Bhd Revenue in Shrimps Disease Diagnostic Business (2019-2024) & (US$ Million)

Table 88. Lab - Ind Resource Sdn Bhd Recent Development

Table 89. AquaBounty Technologies, Inc Company Detail

Table 90. AquaBounty Technologies, Inc Business Overview

Table 91. AquaBounty Technologies, Inc Shrimps Disease Diagnostic Product

Table 92. AquaBounty Technologies, Inc Revenue in Shrimps Disease Diagnostic Business (2019-2024) & (US$ Million)

Table 93. AquaBounty Technologies, Inc Recent Development

Table 94. pop bio Company Detail

Table 95. pop bio Business Overview

Table 96. pop bio Shrimps Disease Diagnostic Product

Table 97. pop bio Revenue in Shrimps Disease Diagnostic Business (2019-2024) & (US$ Million)

Table 98. pop bio Recent Development

Table 99. SUREBIO Company Detail

Table 100. SUREBIO Business Overview

Table 101. SUREBIO Shrimps Disease Diagnostic Product

Table 102. SUREBIO Revenue in Shrimps Disease Diagnostic Business (2019-2024) & (US$ Million)

Table 103. SUREBIO Recent Development

Table 104. Auro Biotechnologies Company Detail

Table 105. Auro Biotechnologies Business Overview

Table 106. Auro Biotechnologies Shrimps Disease Diagnostic Product

Table 107. Auro Biotechnologies Revenue in Shrimps Disease Diagnostic Business (2019-2024) & (US$ Million)

Table 108. Auro Biotechnologies Recent Development

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Shrimps Disease Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Shrimps Disease Diagnostic Market Share by Type: 2023 VS 2030

Figure 3. WSSV (White Spot Syndrome Virus) Features

Figure 4. TSV (Taura Syndrome Virus) Features

Figure 5. YHV/GAV (Yellow Head/Gill Associated Virus) Features

Figure 6. IHHNV (Infectious Hypodermal and Hematopoietic Virus) Features

Figure 7. HPV (Hepatopancreatic Parvovirus) Features

Figure 8. MBV (Monodon Baculovirus) Features

Figure 9. IMNV (Infectious Myonecrosis Virus) Features

Figure 10. NHP-B (Necrotising Hepatopancreatitis Bacteria) Features

Figure 11. MoV (Mourilyan Virus) Features

Figure 12. Early Mortality Syndrome (EMS) Features

Figure 13. Global Shrimps Disease Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 14. Global Shrimps Disease Diagnostic Market Share by Application: 2023 VS 2030

Figure 15. Fisheries Case Studies

Figure 16. Aquaculture Laboratories Case Studies

Figure 17. Marine Laboratories Case Studies

Figure 18. Education and Research Institutes Case Studies

Figure 19. Others Case Studies

Figure 20. Shrimps Disease Diagnostic Report Years Considered

Figure 21. Global Shrimps Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 22. Global Shrimps Disease Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 23. Global Shrimps Disease Diagnostic Market Share by Region: 2023 VS 2030

Figure 24. Global Shrimps Disease Diagnostic Market Share by Players in 2023

Figure 25. Global Top Shrimps Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shrimps Disease Diagnostic as of 2023)

Figure 26. The Top 10 and 5 Players Market Share by Shrimps Disease Diagnostic Revenue in 2023

Figure 27. North America Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. North America Shrimps Disease Diagnostic Market Share by Country (2019-2030)

Figure 29. United States Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Canada Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Europe Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Europe Shrimps Disease Diagnostic Market Share by Country (2019-2030)

Figure 33. Germany Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. France Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. U.K. Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Italy Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Russia Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Nordic Countries Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Asia-Pacific Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Asia-Pacific Shrimps Disease Diagnostic Market Share by Region (2019-2030)

Figure 41. China Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Japan Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Latin America Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Latin America Shrimps Disease Diagnostic Market Share by Country (2019-2030)

Figure 49. Mexico Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Brazil Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Shrimps Disease Diagnostic Market Share by Country (2019-2030)

Figure 53. Turkey Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Shrimps Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. HiMedia Laboratories Revenue Growth Rate in Shrimps Disease Diagnostic Business (2019-2024)

Figure 56. Speedy Assay Sdn Bhd Revenue Growth Rate in Shrimps Disease Diagnostic Business (2019-2024)

Figure 57. REAGEN LLC Revenue Growth Rate in Shrimps Disease Diagnostic Business (2019-2024)

Figure 58. FUJIKURA KASEI CO., LTD Revenue Growth Rate in Shrimps Disease Diagnostic Business (2019-2024)

Figure 59. GeneReach Biotechnology Corp Revenue Growth Rate in Shrimps Disease Diagnostic Business (2019-2024)

Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Shrimps Disease Diagnostic Business (2019-2024)

Figure 61. Lab - Ind Resource Sdn Bhd Revenue Growth Rate in Shrimps Disease Diagnostic Business (2019-2024)

Figure 62. AquaBounty Technologies, Inc Revenue Growth Rate in Shrimps Disease Diagnostic Business (2019-2024)

Figure 63. pop bio Revenue Growth Rate in Shrimps Disease Diagnostic Business (2019-2024)

Figure 64. SUREBIO Revenue Growth Rate in Shrimps Disease Diagnostic Business (2019-2024)

Figure 65. Auro Biotechnologies Revenue Growth Rate in Shrimps Disease Diagnostic Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Asset Management Software Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7H15710

Tue Aug 27 00:00:00 UTC 2024

Add to Cart

Global Drug Interactions Checker Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12A14387

Mon Aug 26 00:00:00 UTC 2024

Add to Cart

Global Elderly Care Service Certification Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0W16001

Wed Aug 21 00:00:00 UTC 2024

Add to Cart

Global Androgen Antagonist Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24N12667

Wed Aug 21 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions